Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00003270 · OUTCOME

Overall Response Rate

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer · Source last updated 2019-12-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
day +100 after Cord Blood Transplant

What was measured

Continuous complete remission (for patients in complete remission before treatment) or induced complete remission (for patients not in complete remission before treatment)

Groups in this outcome

Arm 1

Eligible patients are treated with busulfan IV over 2 hours on days -7 to -4, cyclophosphamide IV over 2 hours on days -3 and -2, antithymocyte globulin (ATG) IV over 10 hours on days -3 to -1 (BuCyATG) and cord blood is infused on day 0; or are treated with cyclophosphamide IV over 2 hours on days -5 and -4, antithymocyte globulin (ATG) IV over 10 hours on days -3 to -1, and undergo TBI twice a day on days -3 to -1 (CyATGTBI) and cord blood is infused on day 0

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm 120

Reported measurements

Source class 1

CR/CCR

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm 112Not reportedNot reportedNot reportedNot reported

Progressed

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm 11Not reportedNot reportedNot reportedNot reported

Not evaluable (early death)

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Arm 17Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        12
      title
      CR/CCR
    2. measurements
      1. group Id
        OG000
        value
        1
      title
      Progressed
    3. measurements
      1. group Id
        OG000
        value
        7
      title
      Not evaluable (early death)
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
description
Continuous complete remission (for patients in complete remission before treatment) or induced complete remission (for patients not in complete remission before treatment)
groups
  1. description
    Eligible patients are treated with busulfan IV over 2 hours on days -7 to -4, cyclophosphamide IV over 2 hours on days -3 and -2, antithymocyte globulin (ATG) IV over 10 hours on days -3 to -1 (BuCyATG) and cord blood is infused on day 0; or are treated with cyclophosphamide IV over 2 hours on days -5 and -4, antithymocyte globulin (ATG) IV over 10 hours on days -3 to -1, and undergo TBI twice a day on days -3 to -1 (CyATGTBI) and cord blood is infused on day 0
    id
    OG000
    title
    Arm 1
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
day +100 after Cord Blood Transplant
title
Overall Response Rate
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice